We are happy to announce that ETAT's application for Scopus has been approved. Within one month, ETAT journal will be listed in the Scopus Title list.
This is a great embodiment of ETAT's rapid development in just two years since launched, and an important step in being acknowledged as a valuable academic publication.
We appreciate all Editors, board members, authors, reviewers, and everyone who has contributed to this.
ETAT’s 2025 CiteScore Rises to 5.4, Marking a 74.19% Increase
Winner of Highly Cited Paper Award 2025
Annual Development Report 2025 of Exploration of Targeted Anti-tumor Therapy
Annual Development Report 2024 of Exploration of Targeted Anti-tumor Therapy